BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37730516)

  • 1. Renal denervation trials in hypertension - what we wait for in 2023/2024.
    Mahfoud F; Kunz M; Götzinger F
    Eur J Intern Med; 2023 Nov; 117():55-56. PubMed ID: 37730516
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of renal sympathetic denervation in hypertension.
    Lateef N; Virk HU; Khan MS; Lakhter V; Haseeb A; Ahsan MJ; Mirza M; Rangaswami J; Zidar DA; Holmberg M; Janzer S
    Future Cardiol; 2020 Jul; 16(4):211-216. PubMed ID: 32166965
    [No Abstract]   [Full Text] [Related]  

  • 3. The Rise and Fall and Rise of Renal Denervation.
    Bhatt DL
    J Am Coll Cardiol; 2022 Nov; 80(20):1881-1883. PubMed ID: 36357088
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal denervation therapy for hypertension: all that glitters is not gold.
    Ram CVS
    Eur Heart J; 2022 Jun; 43(23):2177-2178. PubMed ID: 35171252
    [No Abstract]   [Full Text] [Related]  

  • 5. The Ongoing Odyssey of Renal Denervation.
    Vinayak M; Olin JW; Stone GW
    J Am Coll Cardiol; 2023 Nov; 82(19):1824-1827. PubMed ID: 37914511
    [No Abstract]   [Full Text] [Related]  

  • 6. Can renal denervation replace medications for patients with hypertension?
    Sarathy H; Salman LA
    Lancet; 2022 Apr; 399(10333):1363-1365. PubMed ID: 35390319
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation.
    Patel P; Gupta PK; White CM; Stanley AG; Williams B; Tomaszewski M
    J Hum Hypertens; 2016 Jun; 30(6):368-73. PubMed ID: 26446393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endovascular renal denervation for drug-refractory hypertension : RADIANCE-HTN TRIO].
    Dörr O; Hamm C; Nitschmann S
    Internist (Berl); 2022 Jan; 63(1):129-132. PubMed ID: 34985564
    [No Abstract]   [Full Text] [Related]  

  • 9. [Renal denervation for the treatment of refractory hypertension: where are we?].
    Chiriacò M; Masi S; Pugliese NR; Taddei S
    G Ital Cardiol (Rome); 2020 Dec; 21(12):961-968. PubMed ID: 33231215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 10-Year Outcomes of Catheter-Based Renal Denervation in Patients With Resistant Hypertension.
    Al Ghorani H; Kulenthiran S; Recktenwald MJM; Lauder L; Kunz M; Götzinger F; Ewen S; Ukena C; Böhm M; Mahfoud F
    J Am Coll Cardiol; 2023 Feb; 81(5):517-519. PubMed ID: 36725181
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials.
    Ogoyama Y; Tada K; Abe M; Nanto S; Shibata H; Mukoyama M; Kai H; Arima H; Kario K
    Hypertens Res; 2022 Feb; 45(2):210-220. PubMed ID: 34657140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five special focuses of Hypertension Research: digital hypertension, home blood pressure-centered approach, renal denervation, Asians, for guidelines.
    Kario K; Hoshide S; Mogi M
    Hypertens Res; 2023 Dec; 46(12):2557-2560. PubMed ID: 38049635
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of renal denervation for the management of arterial hypertension: A systematic review and meta-analysis of randomized, sham-controlled, catheter-based trials.
    Stavropoulos K; Patoulias D; Imprialos K; Doumas M; Katsimardou A; Dimitriadis K; Tsioufis C; Papademetriou V
    J Clin Hypertens (Greenwich); 2020 Apr; 22(4):572-584. PubMed ID: 32049436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal denervation for resistant hypertension treatment: a novel team approach.
    Fajadet J
    EuroIntervention; 2012 Oct; 8(6):655-7. PubMed ID: 23086782
    [No Abstract]   [Full Text] [Related]  

  • 16. Medication adherence in hypertension: lessons learned from renal denervation trials.
    Fisher NDL; Mahfoud F
    Eur J Prev Cardiol; 2023 Jan; 30(1):34-36. PubMed ID: 35907251
    [No Abstract]   [Full Text] [Related]  

  • 17. [Denervation denuded].
    de Leeuw PW
    Ned Tijdschr Geneeskd; 2014; 158():A7832. PubMed ID: 24988175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal denervation in patients with chronic kidney disease: current evidence and future perspectives.
    Schmieder RE
    Nephrol Dial Transplant; 2023 May; 38(5):1089-1096. PubMed ID: 35617138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6- and 12-Month Follow-Up From a Randomized Clinical Trial of Ultrasound vs Radiofrequency Renal Denervation (RADIOSOUND-HTN).
    Fengler K; Rommel KP; Kriese W; Blazek S; Besler C; von Roeder M; Desch S; Thiele H; Lurz P
    JACC Cardiovasc Interv; 2023 Feb; 16(3):367-369. PubMed ID: 36792266
    [No Abstract]   [Full Text] [Related]  

  • 20. [Resistant hypertension. Renal denervation is disappointing in a large study].
    Einecke D
    MMW Fortschr Med; 2014 Apr; 156(7):18-9. PubMed ID: 24956641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.